Immediate Impact

3 from Science/Nature 63 standout
Sub-graph 1 of 19

Citing Papers

Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
2024 Standout
2 intermediate papers

Works of Sharon Rose being referenced

Efficacy and safety of fezakinumab (an IL-22 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by conventional treatments: A randomized, double-blind, phase 2a trial
2018
Carnitine deficiency associated with long-term pivampicillin treatment: the effect of a replacement therapy regime
1992

Author Peers

Author Last Decade Papers Cites
Sharon Rose 15 81 24 216 157 19 613
H. L. Ritz 1 47 125 103 114 18 652
Elisabeth Holm 7 157 99 194 27 21 536
Neil A. McEwan 7 126 147 348 168 26 711
Joanna C. Massacand 6 45 97 48 150 8 667
Steve Louie 6 27 102 34 200 8 622
Reina López 10 23 85 99 35 20 704
Pascal Prélaud 8 111 43 499 47 20 692
Jair P. Cunha-Júnior 5 145 83 35 88 39 531
Edvard S. Falk 7 95 257 124 33 26 613
Zemira Samra 13 120 100 26 96 34 517

All Works

Loading papers...

Rankless by CCL
2026